Cargando…

Improved quality of life with home therapy with subcutaneous immunoglobulins for patients with secondary hypogammaglobulinaemia

Detalles Bibliográficos
Autores principales:	Levasseur, Marie-Claude, Haddad, Élie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487831/ http://dx.doi.org/10.1186/1710-1492-8-S1-A26

Ejemplares similares

Treatment costs associated with hospital-based intravenous immunoglobulin therapy compared to home-based subcutaneous immunoglobulin therapy in a cohort of paediatric patients with primary immunodeficiency
por: Ducruet, Thierry, et al.
Publicado: (2011)

Experience with subcutaneous immunoglobulin therapy in two pediatric cases of immune thrombocytopenia purpura
por: Chapdelaine, H, et al.
Publicado: (2012)

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada
por: Gerth, William C, et al.
Publicado: (2014)

A pilot study of quality of life, mood, sleepiness and fatigue in patients with primary humoral immunodeficiency transitioning to subcutaneous immunoglobulin therapy
por: Pourshahnazari, Persia, et al.
Publicado: (2014)

Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis
por: Smilek, Dawn Elaine, et al.
Publicado: (2017)

Basic and clinical immunology – 3030. Subcutaneous immunoglobulin therapy: An option for patients who have experienced thrombotic complications with intravenous therapy
por: Moss, Leslie Anne, et al.
Publicado: (2013)

Good's syndrome: Thymoma with hypogammaglobulinaemia
por: Mathew, Anoop, et al.
Publicado: (2020)

SCIg vs. IVIg: let’s give patients the choice!
por: Samaan, Kathryn K, et al.
Publicado: (2014)

Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
por: Martin, Adriana, et al.
Publicado: (2012)

Evaluation of safety and efficacy of a 20% Subcutaneous Immunoglobulin (Hizentra™), after a dose equivalent switch from intravenous or subcutaneous replacement therapy in a cohort of primary immunodeficient patients
por: Martin, Adriana, et al.
Publicado: (2012)

Tisagenlecleucel: Hypogammaglobulinaemia and pancytopenia: case report
Publicado: (2021)

Rituximab: Hypogammaglobulinaemia: 2 case reports
Publicado: (2021)

Impact of subcutaneous specific-allergen immunotherapy in the quality of life of brazilian moderate/severe atopic dermatitis patients
por: Teixeira, Ana Julia, et al.
Publicado: (2015)

Dementia in a patient with Thymoma and hypogammaglobulinaemia (Good's syndrome)
por: de Jesus, Nelson Pedro Ferreira, et al.
Publicado: (2008)

Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia
por: Briones, Juan, et al.
Publicado: (2013)

Multiple drugs: COVID-19 pneumonia secondary to hypogammaglobulinaemia and off-label use: case report
Publicado: (2022)

Improvement of quality of life in elderly after inguinal hernioplasty
por: Patti, Rodalia, et al.
Publicado: (2011)

Transient hypogammaglobulinaemia of infants in children with mastocytosis – strengthened indications for vaccinations
por: Renke, Joanna, et al.
Publicado: (2016)

Rituximab: Hypogammaglobulinaemia and recurrent COVID-19 infection: case report
Publicado: (2022)

Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada
por: Gerth, William C, et al.
Publicado: (2014)

Bendamustine/obinutuzumab: COVID-19 disease, pancytopenia and hypogammaglobulinaemia: case report
Publicado: (2021)

Case report of Ureaplasma urealyticum meningitis in a patient with thymoma and hypogammaglobulinaemia
por: Zhang, Ting, et al.
Publicado: (2021)

Recurrent COVID‐19 infection in a case of rituximab‐induced hypogammaglobulinaemia
por: Daniel, Jefferson, et al.
Publicado: (2021)

P02-027 - Quality of life in CAPS treated by Canakinumab
por: Marsaud, C, et al.
Publicado: (2013)

Does drug treatment improve patient quality of life? A pilot study of the outcomes of the quality of life assessment in New York City outpatient and opioid treatment programs
por: Nass, Mindy D, et al.
Publicado: (2015)

Diabetes education improves eating habits and quality of life in type 1 diabetes in carbohydrate counting
por: Guimarães, Débora Bohnen, et al.
Publicado: (2015)

Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
por: Da Fonseca, Mario Henrique Almeida, et al.
Publicado: (2015)

Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies
por: Cinetto, Francesco, et al.
Publicado: (2021)

Correction to: Case report of Ureaplasma urealyticum meningitis in a patient with thymoma and hypogammaglobulinaemia
por: Zhang, Ting, et al.
Publicado: (2021)

Multiple drugs: Prolonged course of COVID 19 infection and hypogammaglobulinaemia: case report
Publicado: (2022)

Measured depth of subcutaneous tissue on posterolateral arm of omalizumab patients
por: Potts, Ryan, et al.
Publicado: (2012)

HAART and response to therapy improve quality of life (QOL) of African patients with advanced HIV-associated Kaposi’s sarcoma (HIV-KS): a prospective analysis of QOL in the KAART trial
por: Mosam, Anisa, et al.
Publicado: (2010)

Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency
por: Hoffmann, F, et al.
Publicado: (2010)

Administration and burden of subcutaneous immunotherapy for allergic rhinitis in clinical practice in Canada
por: Blume, Steven W, et al.
Publicado: (2014)

Measured depth of subcutaneous tissue on posterolateral arm of aeroallergen immunotherapy patients
por: Kim, Laura, et al.
Publicado: (2012)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)

Quality of Life (QOL) improvement following catheter-based autologous bone marrow mononuclear cell transplantation (ABM-MCT)
por: Silva, SA, et al.
Publicado: (2003)

Unusual presentation of a patient with complement deficiency and immunoglobulin deficiency
por: Manga, Vaishaali, et al.
Publicado: (2014)

Assessment of food specific immunoglobulin load in pre-school children
por: Jathar, Vithal
Publicado: (2015)

The quality of life in patients treated for rectal cancer
por: Mangiapane, M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g6vgsbf2ucousm2shpd2skugqg